|
COVER STORY
|
 Bt brinjal on the horizon
In a historic move, India’s biotech regulators approved the country’s first biotech food crop, a variety of Bt aubergine or eggplant. It was developed by Monsanto’s Indian joint venture partner, Mahyco
|
|
|
BIOSPECIAL
|
Biologics with a greater reach
An increasing number of global biopharmaceutical companies are outsourcing biomanufacturing (bio-outsourcing) to bring their products to market in a cost-effective and timely fashion. |
Bio-outsourcing holds promise for India
A convergence between the pharma and biotech sector will gradually see both parties leveraging their strengths in drug development, commercialization, discovery and manufacturing capabilities thus delivering innovation and changing the whole landscape of M&A deals. |
Role of biologicals in pandemic
The world is facing an unprecedented threat from swine flu, caused by the now well-known H1N1 virus. Biological preparations can play a very effective role in combating the situation. |
Clinical trial supply market thrives in India
With more and more clinical trials being outsourced to India, it is only logical for sponsors and CROs to start sourcing the clinical trial supplies from within India. |
Marketing strategies for pharma companies
As pharma industry steps into the ‘global local era’ of marketing, it will witness its own share of changes that would indicate the paradigm shift for pharma marketers. |
Redefine pharma marketing for future
If pharma is to create a new marketing and sales model that is fit for 2020, it will have to begin by analyzing its own value chain to identify opportunities for working more closely with healthcare payers and providers. |
Managing clinical research business in modern times
Each area in a CRO operation requires different type of investment and skills—it has a long term bearing on future earnings and business growth. |
Swift diagnosis for technical selling
When it comes to basics like customer service and technical support, several firms find themselves totally out of sync with customer expectations, and the realities in the laboratories or on the shop floor. |
Single Cell Biology: A key research area
Development and commercialization of economical, easier-to-use single cell tools have enabled more researchers to explore this novel area. |
Biological drugs making a difference
The biological drugs have an edge over their chemical counterparts when it comes to safety, and have been largely accepted by both the consumers and the medical community for safer and effective patient treatment. |
Drug delivery using silica nanotubes
The goal of all sophisticated drug delivery systems is to deploy medications to targeted parts of the body, nanotechnology provides the perfect trigger to achieve this. |
Funding, partnering lessons for biotechs
Biotech leaders who want to stay in step with the trends need to rethink how to monitor and then effectively communicate with their investors and big pharma alliance management community. |
Collaboration: The key for vibrant vaccine market in Asia
Successful partnerships with vaccine manufacturers include three critical components. They are industry experience, technical expertise and comprehensive training. |
Different people but less differentiated drugs
A drug can be highly effective for one patient but, the same drug might not show the desired result when given to a second patient with the same diagnosis and even be harmful in a third one. |
Clinical research in India
The unique position of India in clinical research is no accident, but a result of many compounding factors. |
Pall intensifies Asia focus
Pall Life Sciences has evolved from being a filtration and purification products vendor to becoming a complete solution provider to life sciences companies. As part of its growth strategy, Pall is investing significant resources in expanding its operations in Asia. |
